nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Abdominal distress—Methotrexate—colon cancer	0.0595	0.0595	CcSEcCtD
Pentazocine—Miosis—Irinotecan—colon cancer	0.0387	0.0387	CcSEcCtD
Pentazocine—Nodule—Methotrexate—colon cancer	0.0274	0.0274	CcSEcCtD
Pentazocine—Nystagmus—Vincristine—colon cancer	0.0232	0.0232	CcSEcCtD
Pentazocine—Nystagmus—Fluorouracil—colon cancer	0.0217	0.0217	CcSEcCtD
Pentazocine—Ulcer—Irinotecan—colon cancer	0.0171	0.0171	CcSEcCtD
Pentazocine—Ulcer—Fluorouracil—colon cancer	0.0164	0.0164	CcSEcCtD
Pentazocine—Euphoric mood—Fluorouracil—colon cancer	0.0133	0.0133	CcSEcCtD
Pentazocine—Disorientation—Fluorouracil—colon cancer	0.0126	0.0126	CcSEcCtD
Pentazocine—Visual disturbance—Irinotecan—colon cancer	0.0124	0.0124	CcSEcCtD
Pentazocine—Urinary retention—Vincristine—colon cancer	0.0115	0.0115	CcSEcCtD
Pentazocine—Ulcer—Capecitabine—colon cancer	0.0114	0.0114	CcSEcCtD
Pentazocine—Irritability—Fluorouracil—colon cancer	0.0107	0.0107	CcSEcCtD
Pentazocine—Cramp muscle—Irinotecan—colon cancer	0.0106	0.0106	CcSEcCtD
Pentazocine—Sweating increased—Irinotecan—colon cancer	0.00988	0.00988	CcSEcCtD
Pentazocine—Eosinophilia—Fluorouracil—colon cancer	0.00962	0.00962	CcSEcCtD
Pentazocine—Apnoea—Methotrexate—colon cancer	0.0095	0.0095	CcSEcCtD
Pentazocine—Hepatic function abnormal—Capecitabine—colon cancer	0.00899	0.00899	CcSEcCtD
Pentazocine—Sweating—Vincristine—colon cancer	0.0089	0.0089	CcSEcCtD
Pentazocine—Sweating—Irinotecan—colon cancer	0.00867	0.00867	CcSEcCtD
Pentazocine—Ulcer—Methotrexate—colon cancer	0.00852	0.00852	CcSEcCtD
Pentazocine—Hallucination—Vincristine—colon cancer	0.0083	0.0083	CcSEcCtD
Pentazocine—Agranulocytosis—Fluorouracil—colon cancer	0.00808	0.00808	CcSEcCtD
Pentazocine—Diplopia—Capecitabine—colon cancer	0.00786	0.00786	CcSEcCtD
Pentazocine—Visual impairment—Irinotecan—colon cancer	0.00782	0.00782	CcSEcCtD
Pentazocine—Face oedema—Capecitabine—colon cancer	0.00758	0.00758	CcSEcCtD
Pentazocine—Flushing—Irinotecan—colon cancer	0.00754	0.00754	CcSEcCtD
Pentazocine—Irritability—Capecitabine—colon cancer	0.0075	0.0075	CcSEcCtD
Pentazocine—Urinary retention—Capecitabine—colon cancer	0.00747	0.00747	CcSEcCtD
Pentazocine—Chills—Irinotecan—colon cancer	0.00729	0.00729	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00707	0.00707	CcSEcCtD
Pentazocine—Muscle spasms—Irinotecan—colon cancer	0.0068	0.0068	CcSEcCtD
Pentazocine—Agitation—Vincristine—colon cancer	0.00667	0.00667	CcSEcCtD
Pentazocine—Sweating increased—Capecitabine—colon cancer	0.00661	0.00661	CcSEcCtD
Pentazocine—Vertigo—Vincristine—colon cancer	0.00652	0.00652	CcSEcCtD
Pentazocine—Abdominal discomfort—Capecitabine—colon cancer	0.00651	0.00651	CcSEcCtD
Pentazocine—Vision blurred—Fluorouracil—colon cancer	0.00638	0.00638	CcSEcCtD
Pentazocine—Vertigo—Irinotecan—colon cancer	0.00635	0.00635	CcSEcCtD
Pentazocine—Syncope—Irinotecan—colon cancer	0.00634	0.00634	CcSEcCtD
Pentazocine—Hypertension—Vincristine—colon cancer	0.00627	0.00627	CcSEcCtD
Pentazocine—Loss of consciousness—Irinotecan—colon cancer	0.00621	0.00621	CcSEcCtD
Pentazocine—Visual disturbance—Methotrexate—colon cancer	0.00617	0.00617	CcSEcCtD
Pentazocine—Hypertension—Irinotecan—colon cancer	0.0061	0.0061	CcSEcCtD
Pentazocine—Anaphylactic shock—Vincristine—colon cancer	0.00592	0.00592	CcSEcCtD
Pentazocine—Confusional state—Irinotecan—colon cancer	0.00582	0.00582	CcSEcCtD
Pentazocine—Anaphylactic shock—Irinotecan—colon cancer	0.00577	0.00577	CcSEcCtD
Pentazocine—Hyperhidrosis—Vincristine—colon cancer	0.00573	0.00573	CcSEcCtD
Pentazocine—Shock—Irinotecan—colon cancer	0.00568	0.00568	CcSEcCtD
Pentazocine—Agranulocytosis—Capecitabine—colon cancer	0.00565	0.00565	CcSEcCtD
Pentazocine—Anorexia—Vincristine—colon cancer	0.00565	0.00565	CcSEcCtD
Pentazocine—Irritability—Methotrexate—colon cancer	0.00558	0.00558	CcSEcCtD
Pentazocine—Hyperhidrosis—Irinotecan—colon cancer	0.00558	0.00558	CcSEcCtD
Pentazocine—Confusional state—Fluorouracil—colon cancer	0.00557	0.00557	CcSEcCtD
Pentazocine—Hypotension—Vincristine—colon cancer	0.00553	0.00553	CcSEcCtD
Pentazocine—Anaphylactic shock—Fluorouracil—colon cancer	0.00552	0.00552	CcSEcCtD
Pentazocine—Anorexia—Irinotecan—colon cancer	0.0055	0.0055	CcSEcCtD
Pentazocine—Tachycardia—Fluorouracil—colon cancer	0.00539	0.00539	CcSEcCtD
Pentazocine—Hypotension—Irinotecan—colon cancer	0.00539	0.00539	CcSEcCtD
Pentazocine—Insomnia—Vincristine—colon cancer	0.00536	0.00536	CcSEcCtD
Pentazocine—Paraesthesia—Vincristine—colon cancer	0.00532	0.00532	CcSEcCtD
Pentazocine—Anorexia—Fluorouracil—colon cancer	0.00527	0.00527	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00527	0.00527	CcSEcCtD
Pentazocine—Visual impairment—Capecitabine—colon cancer	0.00524	0.00524	CcSEcCtD
Pentazocine—Insomnia—Irinotecan—colon cancer	0.00522	0.00522	CcSEcCtD
Pentazocine—Paraesthesia—Irinotecan—colon cancer	0.00518	0.00518	CcSEcCtD
Pentazocine—Hypotension—Fluorouracil—colon cancer	0.00516	0.00516	CcSEcCtD
Pentazocine—Decreased appetite—Vincristine—colon cancer	0.00515	0.00515	CcSEcCtD
Pentazocine—Dyspnoea—Irinotecan—colon cancer	0.00514	0.00514	CcSEcCtD
Pentazocine—Erythema multiforme—Capecitabine—colon cancer	0.00514	0.00514	CcSEcCtD
Pentazocine—Somnolence—Irinotecan—colon cancer	0.00513	0.00513	CcSEcCtD
Pentazocine—Tinnitus—Capecitabine—colon cancer	0.00507	0.00507	CcSEcCtD
Pentazocine—Constipation—Vincristine—colon cancer	0.00507	0.00507	CcSEcCtD
Pentazocine—Flushing—Capecitabine—colon cancer	0.00504	0.00504	CcSEcCtD
Pentazocine—Decreased appetite—Irinotecan—colon cancer	0.00501	0.00501	CcSEcCtD
Pentazocine—Eosinophilia—Methotrexate—colon cancer	0.005	0.005	CcSEcCtD
Pentazocine—Insomnia—Fluorouracil—colon cancer	0.005	0.005	CcSEcCtD
Pentazocine—Paraesthesia—Fluorouracil—colon cancer	0.00496	0.00496	CcSEcCtD
Pentazocine—Constipation—Irinotecan—colon cancer	0.00493	0.00493	CcSEcCtD
Pentazocine—Dyspnoea—Fluorouracil—colon cancer	0.00493	0.00493	CcSEcCtD
Pentazocine—Somnolence—Fluorouracil—colon cancer	0.00491	0.00491	CcSEcCtD
Pentazocine—Chills—Capecitabine—colon cancer	0.00488	0.00488	CcSEcCtD
Pentazocine—Abdominal discomfort—Methotrexate—colon cancer	0.00485	0.00485	CcSEcCtD
Pentazocine—Decreased appetite—Fluorouracil—colon cancer	0.0048	0.0048	CcSEcCtD
Pentazocine—Feeling abnormal—Irinotecan—colon cancer	0.00475	0.00475	CcSEcCtD
Pentazocine—Dysgeusia—Capecitabine—colon cancer	0.00463	0.00463	CcSEcCtD
Pentazocine—Feeling abnormal—Fluorouracil—colon cancer	0.00455	0.00455	CcSEcCtD
Pentazocine—Muscle spasms—Capecitabine—colon cancer	0.00455	0.00455	CcSEcCtD
Pentazocine—Vision blurred—Capecitabine—colon cancer	0.00446	0.00446	CcSEcCtD
Pentazocine—Tremor—Capecitabine—colon cancer	0.00443	0.00443	CcSEcCtD
Pentazocine—Hypersensitivity—Vincristine—colon cancer	0.00436	0.00436	CcSEcCtD
Pentazocine—Sweating—Methotrexate—colon cancer	0.00432	0.00432	CcSEcCtD
Pentazocine—Vertigo—Capecitabine—colon cancer	0.00425	0.00425	CcSEcCtD
Pentazocine—Hypersensitivity—Irinotecan—colon cancer	0.00425	0.00425	CcSEcCtD
Pentazocine—Asthenia—Vincristine—colon cancer	0.00425	0.00425	CcSEcCtD
Pentazocine—Syncope—Capecitabine—colon cancer	0.00424	0.00424	CcSEcCtD
Pentazocine—Agranulocytosis—Methotrexate—colon cancer	0.00421	0.00421	CcSEcCtD
Pentazocine—Loss of consciousness—Capecitabine—colon cancer	0.00416	0.00416	CcSEcCtD
Pentazocine—Asthenia—Irinotecan—colon cancer	0.00414	0.00414	CcSEcCtD
Pentazocine—Hypertension—Capecitabine—colon cancer	0.00408	0.00408	CcSEcCtD
Pentazocine—Hypersensitivity—Fluorouracil—colon cancer	0.00407	0.00407	CcSEcCtD
Pentazocine—Diarrhoea—Vincristine—colon cancer	0.00405	0.00405	CcSEcCtD
Pentazocine—Diarrhoea—Irinotecan—colon cancer	0.00395	0.00395	CcSEcCtD
Pentazocine—Dry mouth—Capecitabine—colon cancer	0.00394	0.00394	CcSEcCtD
Pentazocine—Dizziness—Vincristine—colon cancer	0.00392	0.00392	CcSEcCtD
Pentazocine—Pruritus—Fluorouracil—colon cancer	0.00391	0.00391	CcSEcCtD
Pentazocine—Visual impairment—Methotrexate—colon cancer	0.0039	0.0039	CcSEcCtD
Pentazocine—Confusional state—Capecitabine—colon cancer	0.00389	0.00389	CcSEcCtD
Pentazocine—Erythema multiforme—Methotrexate—colon cancer	0.00382	0.00382	CcSEcCtD
Pentazocine—Dizziness—Irinotecan—colon cancer	0.00381	0.00381	CcSEcCtD
Pentazocine—Shock—Capecitabine—colon cancer	0.0038	0.0038	CcSEcCtD
Pentazocine—Diarrhoea—Fluorouracil—colon cancer	0.00378	0.00378	CcSEcCtD
Pentazocine—Tinnitus—Methotrexate—colon cancer	0.00377	0.00377	CcSEcCtD
Pentazocine—Tachycardia—Capecitabine—colon cancer	0.00377	0.00377	CcSEcCtD
Pentazocine—Vomiting—Vincristine—colon cancer	0.00377	0.00377	CcSEcCtD
Pentazocine—Hyperhidrosis—Capecitabine—colon cancer	0.00373	0.00373	CcSEcCtD
Pentazocine—Dermatitis—Vincristine—colon cancer	0.00373	0.00373	CcSEcCtD
Pentazocine—Headache—Vincristine—colon cancer	0.00371	0.00371	CcSEcCtD
Pentazocine—Anorexia—Capecitabine—colon cancer	0.00368	0.00368	CcSEcCtD
Pentazocine—Vomiting—Irinotecan—colon cancer	0.00367	0.00367	CcSEcCtD
Pentazocine—Dizziness—Fluorouracil—colon cancer	0.00365	0.00365	CcSEcCtD
Pentazocine—Dermatitis—Irinotecan—colon cancer	0.00363	0.00363	CcSEcCtD
Pentazocine—Chills—Methotrexate—colon cancer	0.00363	0.00363	CcSEcCtD
Pentazocine—Headache—Irinotecan—colon cancer	0.00361	0.00361	CcSEcCtD
Pentazocine—Hypotension—Capecitabine—colon cancer	0.00361	0.00361	CcSEcCtD
Pentazocine—Nausea—Vincristine—colon cancer	0.00352	0.00352	CcSEcCtD
Pentazocine—Vomiting—Fluorouracil—colon cancer	0.00351	0.00351	CcSEcCtD
Pentazocine—Insomnia—Capecitabine—colon cancer	0.00349	0.00349	CcSEcCtD
Pentazocine—Dermatitis—Fluorouracil—colon cancer	0.00348	0.00348	CcSEcCtD
Pentazocine—Paraesthesia—Capecitabine—colon cancer	0.00347	0.00347	CcSEcCtD
Pentazocine—Headache—Fluorouracil—colon cancer	0.00346	0.00346	CcSEcCtD
Pentazocine—Dysgeusia—Methotrexate—colon cancer	0.00345	0.00345	CcSEcCtD
Pentazocine—Dyspnoea—Capecitabine—colon cancer	0.00344	0.00344	CcSEcCtD
Pentazocine—Nausea—Irinotecan—colon cancer	0.00343	0.00343	CcSEcCtD
Pentazocine—Decreased appetite—Capecitabine—colon cancer	0.00336	0.00336	CcSEcCtD
Pentazocine—Vision blurred—Methotrexate—colon cancer	0.00332	0.00332	CcSEcCtD
Pentazocine—Constipation—Capecitabine—colon cancer	0.0033	0.0033	CcSEcCtD
Pentazocine—Nausea—Fluorouracil—colon cancer	0.00328	0.00328	CcSEcCtD
Pentazocine—Feeling abnormal—Capecitabine—colon cancer	0.00318	0.00318	CcSEcCtD
Pentazocine—Vertigo—Methotrexate—colon cancer	0.00316	0.00316	CcSEcCtD
Pentazocine—Confusional state—Methotrexate—colon cancer	0.0029	0.0029	CcSEcCtD
Pentazocine—Anaphylactic shock—Methotrexate—colon cancer	0.00287	0.00287	CcSEcCtD
Pentazocine—Hypersensitivity—Capecitabine—colon cancer	0.00284	0.00284	CcSEcCtD
Pentazocine—Hyperhidrosis—Methotrexate—colon cancer	0.00278	0.00278	CcSEcCtD
Pentazocine—Asthenia—Capecitabine—colon cancer	0.00277	0.00277	CcSEcCtD
Pentazocine—Anorexia—Methotrexate—colon cancer	0.00274	0.00274	CcSEcCtD
Pentazocine—Pruritus—Capecitabine—colon cancer	0.00273	0.00273	CcSEcCtD
Pentazocine—Hypotension—Methotrexate—colon cancer	0.00269	0.00269	CcSEcCtD
Pentazocine—Diarrhoea—Capecitabine—colon cancer	0.00264	0.00264	CcSEcCtD
Pentazocine—Insomnia—Methotrexate—colon cancer	0.0026	0.0026	CcSEcCtD
Pentazocine—Paraesthesia—Methotrexate—colon cancer	0.00258	0.00258	CcSEcCtD
Pentazocine—Dyspnoea—Methotrexate—colon cancer	0.00256	0.00256	CcSEcCtD
Pentazocine—Somnolence—Methotrexate—colon cancer	0.00255	0.00255	CcSEcCtD
Pentazocine—Dizziness—Capecitabine—colon cancer	0.00255	0.00255	CcSEcCtD
Pentazocine—Decreased appetite—Methotrexate—colon cancer	0.0025	0.0025	CcSEcCtD
Pentazocine—Vomiting—Capecitabine—colon cancer	0.00245	0.00245	CcSEcCtD
Pentazocine—Dermatitis—Capecitabine—colon cancer	0.00243	0.00243	CcSEcCtD
Pentazocine—Headache—Capecitabine—colon cancer	0.00242	0.00242	CcSEcCtD
Pentazocine—Feeling abnormal—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Pentazocine—Nausea—Capecitabine—colon cancer	0.00229	0.00229	CcSEcCtD
Pentazocine—Hypersensitivity—Methotrexate—colon cancer	0.00212	0.00212	CcSEcCtD
Pentazocine—Asthenia—Methotrexate—colon cancer	0.00206	0.00206	CcSEcCtD
Pentazocine—Pruritus—Methotrexate—colon cancer	0.00203	0.00203	CcSEcCtD
Pentazocine—Diarrhoea—Methotrexate—colon cancer	0.00197	0.00197	CcSEcCtD
Pentazocine—Dizziness—Methotrexate—colon cancer	0.0019	0.0019	CcSEcCtD
Pentazocine—Vomiting—Methotrexate—colon cancer	0.00183	0.00183	CcSEcCtD
Pentazocine—Dermatitis—Methotrexate—colon cancer	0.00181	0.00181	CcSEcCtD
Pentazocine—Headache—Methotrexate—colon cancer	0.0018	0.0018	CcSEcCtD
Pentazocine—Nausea—Methotrexate—colon cancer	0.00171	0.00171	CcSEcCtD
